Abstract
Rationale
Published studies examining the effects of cannabis have largely utilized forms of cannabis that are not representative of the legal market products currently available.
Objectives
The present study aimed to characterize naturalistic use of legal market flower and edible products by examining associations among blood cannabinoids and amount of THC consumed as well as physiological, cognitive, and subjective effects in users of edible and flower forms.
Method
Eighty-four participants who used cannabis at least 1 × /week (55 flower cannabis using participants; 29 edible cannabis using participants mean age = 31.95 years, 44% female) participated. At the experimental appointment in our mobile laboratory, participants completed a blood draw to assess plasma cannabinoids, measures of heart rate, subjective drug effects, and cognition both before and after ad libitum use of legal market flower or edible cannabis.
Results
Average self-reported THC consumed was 15.97 mg (SD = 22.40) in edible users and 51.25 mg (SD = 45.23) in flower users. In the edible group, but not the flower group, strong correlations emerged between self-reported ad libitum THC consumed and plasma THC. Plasma THC was significantly higher after use of inhaled cannabis, but similar levels of plasma THC metabolites and similar levels of subjective intoxication and verbal memory impairment were observed in both flower and edible users.
Conclusions
Findings support strong correlations among ad libitum THC consumed and THC plasma levels after edible cannabis use and suggest few differences in intoxication and impairment between edible and flower cannabis users after ad libitum use. This novel study provides important preliminary data on the pharmacology and effects of legal market edible cannabis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barrus DG, Capogrossi KL, Cates SC, et al (2016) Tasty THC: promises and challenges of cannabis edibles. Methods Rep RTI Press 2016. https://doi.org/10.3768/rtipress.2016.op.0035.1611
Beck AT, Steer RA, Carbin MG (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8:77–100. https://doi.org/10.1016/0272-7358(88)90050-5
Beck AT, Steer RA (1990) Manual for the Beck anxiety inventory
Bidwell LC, Mueller R, YorkWilliams SL et al (2018) A novel observational method for assessing acute responses to cannabis : preliminary validation using legal market strains. Cannabis Cannabinoid Res 3:35–44. https://doi.org/10.1089/can.2017.0038
Bidwell LC, Ellingson JM, Karoly HC, et al (2020) Naturalistic administration of cannabis flower and concentrates: cannabinoid blood levels, subjective intoxication, cognition and motor function. JAMA psychiatry
Cannabis H, Reports M (2019) Food for thought : edibles enjoy solid sales, steady growth
Chait LD, Zacny JP (1992) Reinforcing and subjective effects of oral ??9-THC and smoked marijuana in humans. Psychopharmacology 107:255–262. https://doi.org/10.1007/BF02245145
Chait LD, Zacny JP (1992) Reinforcing and subjective effects of oral Δ9-THC and smoked marijuana in humans. Psychopharmacology 107:255–262. https://doi.org/10.1007/BF02245145
Córdova L, Humphreys H, Amend C, et al (2020) MED 2019 Annual Update. 1–16
Englund A, Morrison PD, Nottage J et al (2013) Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. J Psychopharmacol 27:19–27. https://doi.org/10.1177/0269881112460109
Ewusi Boisvert E, Bae D, Pang RD, et al (2020) Subjective effects of combustible, vaporized, and edible cannabis: Results from a survey of adolescent cannabis users. Drug Alcohol Depend 206.https://doi.org/10.1016/j.drugalcdep.2019.107716
Freeman AM, Petrilli K, Lees R et al (2019) How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review. Neurosci Biobehav Rev 107:696–712
Hart CL, Ward AS, Haney M et al (2002) Comparison of smoked marijuana and oral D 9-tetrahydrocannabinol in humans. Psychopharmacology 164:407–415. https://doi.org/10.1007/s00213-002-1231-y
Hasin DS (2018) US epidemiology of cannabis use and associated problems. Neuropsychopharmacology 43:195–212
Huestis MA (2007) Human cannabinoid pharmacokinetics. Chem Biodivers 4:1770–1804. https://doi.org/10.1002/cbdv.200790152
Huestis MA, Henningfield JE, Cone EJ (1992) Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 16:276–82
Krebs MO, Kebir O, Jay TM (2019) Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders. Eur J Pain (UK) 23:1225–1233
Lemberger L, Weiss JL, Watanabe AM et al (1972) Delta-9-tetrahydrocannabinol — Temporal correlation of the Psychologic effects and blood levels after various routes of administration. N Engl J Med 286:685–688. https://doi.org/10.1056/NEJM197203302861303
Light MK, Orens A, Lewandowski B, Pickton T (2014) Market size and demand for marijuana in Colorado. Colorado Department of Revenue, Denver
McDonald J, Schleifer L, Richards JB, De Wit H (2003) Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28:1356–1365. https://doi.org/10.1038/sj.npp.1300176
McNair DM, Lorr M, Droppleman LF (1971) Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego
Murphy F, Sales P, Murphy S et al (2015) Baby boomers and cannabis delivery systems. J Drug Issues 45:293–313. https://doi.org/10.1177/0022042615580991
Nadulski T, Sporkert F, Schnelle M et al (2005) Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract. J Anal Toxicol 29:782–789. https://doi.org/10.1093/jat/29.8.782
Newmeyer MN, Swortwood MJ, Abulseoud OA, Huestis MA (2017) Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration. Drug Alcohol Depend 175:67–76. https://doi.org/10.1016/j.drugalcdep.2017.02.003
Ohlsson A, Lindgren J-E, Wahlen A et al (1980) Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28:409–416. https://doi.org/10.1038/clpt.1980.181
Ohlsson A, Lindgren J-E, Andersson S et al (1986) Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biol Mass Spectrom 13:77–83. https://doi.org/10.1002/bms.1200130206
Orens A, Light M, Lewandowski B, et al (2018) 2017 Market Update. Denver, Colorado
Pacula RL, Jacobson M, Maksabedian EJ (2016) In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction 111:973–980. https://doi.org/10.1111/add.13282
Poyatos L, Pérez-Acevedo AP, Papaseit E et al (2020) Oral administration of cannabis and Δ-9-tetrahydrocannabinol (Thc) preparations: a systematic review. Med 56:1–28. https://doi.org/10.3390/medicina56060309
S. W, M. E, S. R, et al (2002) Comparison of the subjective effects of Δ 9 -tetrahydrocannabinol and marijuana in humans. Psychopharmacology (Berl) 161:331–339. https://doi.org/10.1007/s00213-002-1033-2
Saunders JB, Aasland OG, Babor TF et al (1993) Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 88:791–804
Sholler DJ, Strickland JC, Spindle TR, et al (2020) Sex differences in the acute effects of oral and vaporized cannabis among healthy adults. Addict Biol 1–12.https://doi.org/10.1111/adb.12968
Sobell LC, Maisto SA, Sobell MB, Cooper AM (1979) Reliability of alcohol abusers’ self-reports of drinking behavior. Behav Res Ther 17:157–160. https://doi.org/10.1016/0005-7967(79)90025-1
Spindle TR, Cone EJ, Goffi E et al (2020) Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users. Drug Alcohol Depend 211:107937
Spindle TR, Martin EL, Grabenauer M, et al (2021) Assessment of cognitive and psychomotor impairment , subjective effects , and blood THC concentrations following acute administration of oral and vaporized cannabis. https://doi.org/10.1177/02698811211021583
State Medical Marijuana Laws. https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx. Accessed 12 Jan 2021
Stephens RS, Roffman RA, Curtin L (2000) Comparison of extended versus brief treatment for marijuana use. J Consult Clin Psychol 68:898–908. https://doi.org/10.1037/0022-006X.68.5.898
Team RC (2013) R: A language and environment for statistical computing. R Foundation for Statistical Computing
Thompson TAC, Wilson PH, Snyder PJ, et al (2011) Sensitivity and test–retest reliability of the international shopping list test in assessing verbal learning and memory in mild Alzheimer’s disease. Oxford Univ Press
Vandrey R, Raber JC, Raber ME et al (2015) Cannabinoid dose and label accuracy in edible medical cannabis products. JAMA J Am Med Assoc 313:2491–2493. https://doi.org/10.1001/jama.2015.6613
Vann RE, Gamage TF, Warner JA et al (2008) Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol. Drug Alcohol Depend 94:191–198. https://doi.org/10.1016/j.drugalcdep.2007.11.017
Wachtel SR, ElSohly MA, Ross SA et al (2002) Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacology 161:331–339. https://doi.org/10.1007/s00213-002-1033-2
Weinkle L, Domen CH, Shelton I et al (2019) Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal. Mult Scler Relat Disord 27:383–390. https://doi.org/10.1016/j.msard.2018.11.022
Weintraub S, Dikmen SS, Heaton RK et al (2013) Cognition assessment using the NIH Toolbox. Neurology 80:S54-64. https://doi.org/10.1212/WNL.0b013e3182872ded
Funding
Funding for this study was provided by a grant from the National Institutes of Health (DA039707 to KEH).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bidwell, L.C., Karoly, H.C., Torres, M.O. et al. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment. Psychopharmacology 239, 385–397 (2022). https://doi.org/10.1007/s00213-021-06007-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-021-06007-2